BLOOD: One 4 mL lavender top (EDTA), 4 mL green top (sodium heparin) or 6 mL yellow top tube (ACD); BODY FLUID: At least 5 mL fluid preferred. For fluids with low cell counts, larger volumes will improve results.
BONE MARROW, BLOOD, or BODY FLUIDS: Mix with equal volumes of RPMI media, available from Client Services. Submit to laboratory within 24 hours.
DNA ploidy analysis provides correlative information of use in the staging of tumors. Ploidy analysis provides indication of whether a tumor has a normal component of chromosomes (diploid) or an abnormal number (aneuploid). The percentage of cells which are in active growth (S-phase) can also be enumerated. Generally, tumors which are aneuploid and have high S-phase percentages behave more aggressively.
Insufficient cells for analysis; excessive necrosis and debris.
MEDICARE MAY REQUIRE A SIGNED ADVANCE BENEFICIARY NOTICE (ABN) FOR THIS TEST